1-7 of 7
Authors: Masamichi Takahashi
Journal Article
Early progressive disease within 2 years in isocitrate dehydrogenase (IDH)–mutant astrocytoma may indicate radiation necrosis Get access
Japanese Journal of Clinical Oncology, Volume 55, Issue 2, February 2025, Pages 106–112, https://doi.org/10.1093/jjco/hyae151
Published: 11 December 2024
Journal Article
Consulting a neurosurgeon upon initial medical assessment reduces the time to the first surgery and potentially contributes to improved prognosis for glioblastoma patients Free
Japanese Journal of Clinical Oncology, Volume 53, Issue 11, November 2023, Pages 1027–1033, https://doi.org/10.1093/jjco/hyad093
Published: 02 August 2023
Journal Article
Continuing maintenance temozolomide therapy beyond 12 cycles confers no clinical benefit over discontinuation at 12 cycles in patients with IDH1/2-wildtype glioblastoma Free
Japanese Journal of Clinical Oncology, Volume 52, Issue 10, October 2022, Pages 1134–1142, https://doi.org/10.1093/jjco/hyac114
Published: 21 July 2022
Journal Article
Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment** Free
Japanese Journal of Clinical Oncology, Volume 51, Issue 7, July 2021, Pages 1028–1035, https://doi.org/10.1093/jjco/hyab063
Published: 06 May 2021
Journal Article
Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module Free
Japanese Journal of Clinical Oncology, Volume 50, Issue 7, July 2020, Pages 787–793, https://doi.org/10.1093/jjco/hyaa036
Published: 13 April 2020
Journal Article
Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma Get access
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 512–518, https://doi.org/10.1093/jjco/hyaa010
Published: 04 March 2020
Journal Article
Immunochemotherapy using rituximab (RTX) and high-dose methotrexate (HD-MTX): an evaluation of the addition of RTX to HD-MTX in recurrent primary central nervous system lymphoma (PCNSL) Get access
Japanese Journal of Clinical Oncology, Volume 47, Issue 10, October 2017, Pages 919–924, https://doi.org/10.1093/jjco/hyx095
Published: 05 July 2017
